Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells

Gene Therapy

Volumn 17, Issue 8, 2010, Pages 1052-1061

  Park, S H ^a   Doh, J ^a   Park, S I ^b   Lim, J Y ^b   Kim, S M ^b   Youn, J I ^a   Jin, H T ^c   Seo, S H ^a   Song, M Y ^a   Sung, S Y ^a   Kim, M ^a   Hwang, S J ^b   Choi, J M ^d,e   Lee, S K ^d   Lee, H Y ^f   Lim, C L ^f   Chung, Y J ^f   Yang, D ^g   Kim, H N ^g   Lee, Z H ^g   Choi, K Y ^a   Jeun, S S ^b   Sung, Y C ^a   more..

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c POSTECH Biotech Center   (South Korea)

^d Yonsei University   (South Korea)

^e Hanyang University   (South Korea)

^f Kolon Life Science Research Institute   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

BDNF; BMP2; cell permeable peptide; mesenchymal stem cell; oligomerization; recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; BRAIN DERIVED NEUROTROPHIC FACTOR; PEPTIDE; TRANSACTIVATOR PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SPINAL CORD INJURY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BONE DISEASES; BONE MORPHOGENETIC PROTEIN 2; CELL-PENETRATING PEPTIDES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; SKULL; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 77955657416     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.58     Document Type: Article

References (39)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-884.
3. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180: 2581-2587.
4. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846-12851.
5. Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 329-340.
6. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-3506.
7. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 2005; 5: 1571-1584.
8. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Therapy 2008; 15: 109-116.
9. Wilson JM. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185-1187.
10. Volpers C, Kochanek S. Adenoviral vectors for gene transfer and therapy. J Gene Med 2004; 6 (Suppl 1): S164-S171.
11. Wang Y, Liu S, Li CY, Yuan F. A novel method for viral gene delivery in solid tumors. Cancer Res 2005; 65: 7541-7545.
12. Tsuda H, Wada T, Ito Y, Uchida H, Dehari H, Nakamura K et al. Efficient BMP2 gene transfer and bone formation of mesen-chymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 2003; 7: 354-365.
13. Mizuguchi H, Sasaki T, Kawabata K, Sakurai F, Hayakawa T. Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchy-mal stem cells. Biochem Biophys Res Commun 2005; 332: 1101-1106.
14. Knaan-Shanzer S, van de Watering MJ, van der Velde I, Goncalves MA, Valerio D, de Vries AA. Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 2005; 23: 1598-1607.
15. Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Hickey R et al. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 2003; 9: 357-362.
16. Youn JI, Park SH, Jin HT, Lee CG, Seo SH, Song MY et al. Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. Cancer Gene Ther 2008; 15: 703-712.
17. Kawamura KS, Sung M, Bolewska-Pedyczak E, Gariepy J. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells. Biochemistry 2006; 45: 1116-1127.
18. Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003; 278: 11411-11418.
19. Johnson JR, Jiang H, Smith BD. Zinc(II)-coordinated oligo-tyrosine: a new class of cell penetrating peptide. Bioconjug Chem 2008; 19: 1033-1039.
20. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997; 272: 16010-16017.
21. Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, Song HM et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006; 12: 574-579.
22. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 1996; 271: 18188-18193.
23. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84-A: 2123-2134.
24. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991; 252: 554-558.
25. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244-256.
26. Kuh SU, Cho YE, Yoon DH, Kim KN, Ha Y. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 2005; 147: 985-992; discussion 992.
27. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002; 245: 1-7.
28. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276: 5836-5840.
29. Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K et al. Use of protamine to augment adenovirus-mediated cancer gene therapy. Gene Therapy 1999; 6: 1600-1610.
30. Toyoda K, Nakane H, Heistad DD. Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo. J Cereb Blood Flow Metab 2001; 21: 1125-1131.
31. Kuhnel F, Schulte B, Wirth T, Woller N, Schafers S, Zender L et al. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol 2004; 78: 13743-13754.
32. Kurachi S, Tashiro K, Sakurai F, Sakurai H, Kawabata K, Yayama K et al. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity. Gene Therapy 2007; 14: 1160-1165.
33. Han T, Tang Y, Ugai H, Perry LE, Siegal GP, Contreras JL et al. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy. Virol J 2007; 4: 103.
34. Ha SJ, Chang J, Song MK, Suh YS, Jin HT, Lee CH et al. Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. Nat Biotechnol 2002; 20: 381-386.
35. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585-590.
36. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003; 21: 513-518.
37. Choi JS, Kim HY, Cha JH, Choi JY, Park SI, Jeong CH et al. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J Histochem Cytochem 2007; 55: 821-830.
38. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
39. Takami T, Oudega M, Bethea JR, Wood PM, Kleitman N, Bunge MB. Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma 2002; 19: 653-666.